Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Yesterday, Health Net Inc. ( HNT - Analyst Report ) announced that its subsidiaries have terminated their 3-year contract with 6 hospitals of Tenet Healthcare Corp. ( THC - Analyst Report ) in Southern California. The contract termination resulted due to the inability of the companies to reach an agreement regarding the terms for extension. Health Net was in favor of changing the reimbursement rates offered by Tenet Healthcare considering the present market condition in California.
The company wanted to bring the reimbursement rate at par with the medical consumer price index, which currently exceeds the 3% mark. Additionally, Health Net wanted the reimbursement rate for those programs, which are financed by the state or federal government, to be based on the funding of these programs. However, these terms were not acceptable to Tenet Healthcare.
Consequently, the two companies failed to reach an agreement and Health Net decided to use its contractual option to terminate the agreements with all 6 Tenet Healthcare hospitals. The agreements have been terminated with effect from December 21, 2012. The company had agreements with Desert Regional Medical Center, Fountain Valley Hospital and Medical Center, John F. Kennedy Memorial Hospital, Lakewood Regional Medical Center, Los Alamitos Medical Center and Placentia Linda Hospital.
Health Net believes that the current reimbursement rates were not reasonable and increased the health care costs of its customers. The increasing cost went against the company’s objective of providing reasonably priced health care to its clientele. Thus, it prematurely terminated the contract, which was already on the verge on expiration.
Both Health Net and Tenet Healthcare currently carry a Zacks #2 Rank (Buy). We also maintain a long-term ‘Neutral’ recommendation on the stocks.
Read the full reports :
Analyst Report on THC
Analyst Report on HNT